These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1079321)

  • 1. Letter: Proportion of E rosettes normal in Graves's and Hashimoto's disease: a retraction.
    Volpé R; Row VV
    N Engl J Med; 1975 Jul; 293(1):44. PubMed ID: 1079321
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral thymus-dependent (T) lymphocytes in Graves's disease and Hashimoto's thyroiditis.
    Farid NR; Munro RE; Row VV; Volpé R
    N Engl J Med; 1973 Jun; 288(25):1313-7. PubMed ID: 4122370
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM; Liu W; Lu GH
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of subgroups of euthyroid graves's ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith FJ
    N Engl J Med; 1977 Jan; 296(4):181-6. PubMed ID: 576175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosette inhibition test for the demonstration of thymus-dependent lymphocyte sensitization in Graves's disease and Hashimoto's thyroiditis.
    Farid NR; Munro RE; Row VV; Volpé R
    N Engl J Med; 1973 Nov; 289(21):1111-7. PubMed ID: 4127831
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: E-rosette formation specific for T lymphocytes.
    Farid NR; Row VV; Volpé R
    N Engl J Med; 1974 Apr; 290(17):970. PubMed ID: 4544653
    [No Abstract]   [Full Text] [Related]  

  • 7. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
    Chan JY; Walfish PG
    Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadal dysgenesis with Graves's disease.
    Brooks WH; Meek JC; Schimke RN
    J Med Genet; 1977 Apr; 14(2):128-9. PubMed ID: 576874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis.
    Hammond LJ; Lowdell MW; Cerrano PG; Goode AW; Bottazzo GF; Mirakian R
    J Pathol; 1997 Jun; 182(2):138-44. PubMed ID: 9274522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T-cells and B-cells in the peripheral blood in Basedow's disease and Hashimoto's disease].
    Oshima K; Inazawa M; Awashima S; Katakai S; Ozawa K
    Horumon To Rinsho; 1978 Jan; 26(1):25-9. PubMed ID: 308417
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis.
    Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Yamauchi K; Itatsu T; Takatsuki K; Saito H
    J Clin Endocrinol Metab; 1989 Jul; 69(1):100-4. PubMed ID: 2567295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Rosette inhibition in Graves's disease.
    Chapel HM; Batchelor JR
    N Engl J Med; 1974 Jul; 291(2):103. PubMed ID: 4406909
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitization of T-lymphocytes in Graves' and Hashimoto's diseases.
    Okita N; Kidd A; Row VV; Volpé R
    J Clin Endocrinol Metab; 1980 Aug; 51(2):316-20. PubMed ID: 6249836
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated immunity in thyroid disease.
    Farid NR; Munro RE; Row VV; Volpé R
    Br Med J; 1973 Mar; 1(5854):677. PubMed ID: 4540302
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.
    Hidaka Y; Okumura M; Shimaoka Y; Takeoka K; Tada H; Amino N
    Thyroid; 1998 Mar; 8(3):235-9. PubMed ID: 9545110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' ophthalmopathy, ocular myasthenia gravis and Hashimoto's thyroiditis.
    Czernobilsky H; Ziegler R
    Isr J Med Sci; 1985 Apr; 21(4):377-80. PubMed ID: 3873447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The autoimmune infiltrate of Basedow's disease: analysis of clonal level and comparison with Hashimoto's thyroiditis.
    Mariotti S; del Prete GF; Mastromauro C; de Carli M; Romagnani S; Ricci M; Pinchera A
    Exp Clin Endocrinol; 1991 May; 97(2-3):139-46. PubMed ID: 1680724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
    Chan JY; Walfish PG
    J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocytes in Hashimoto's thyroiditis.
    Urbaniak SJ; Penhale WJ; Irvine WJ
    Lancet; 1973 Aug; 2(7826):452-3. PubMed ID: 4124945
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
    Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.